Daanbiotpx
3 known investors
DAAN Biotherapeutics develops T-cell immunotherapies for cancer, including TCR-T cell therapies, TCR-mimic T-cell engagers, and conditionally activated T-cell engagers targeting tumor-specific antigens. The company is building an immuno-oncology pipeline aimed at improving precision and reducing toxicity for patients with cancer.
BiotechHealthtech